Home Featured Page 264

Featured

Latest

The Problems We Will Be Lucky to Have

Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date

Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It

Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona

Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine

Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill...

PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research

Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional...

Navigating Psychedelics for Clinicians and Therapists Course: Informational Meeting with Joe...

PT251 – Kristina & Jonas of the Psychedelic Literacy Fund –...

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and...

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding...

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

What Is Transpersonal Psychology and How Does It Relate to Psychedelics?

COMPASS Pathways launches new podcast “Everyone has a story: talking about...

EDITOR PICKS

The Problems We Will Be Lucky to Have

Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House...

Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Problems We Will Be Lucky to Have

Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date

Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It

Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona

Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine

Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill...

PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research

Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional...

Navigating Psychedelics for Clinicians and Therapists Course: Informational Meeting with Joe...

PT251 – Kristina & Jonas of the Psychedelic Literacy Fund –...

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and...

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding...

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

What Is Transpersonal Psychology and How Does It Relate to Psychedelics?

COMPASS Pathways launches new podcast “Everyone has a story: talking about...

EDITOR PICKS

The Problems We Will Be Lucky to Have

Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House...

Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY